Chi Chiu Mok (C Mok, C C Mok)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 50

Top Topics

Cerebrospinal Fluid

Disease Activity

Systemic Lupus Erythematosus

Top Venues

Expert opinion on biological therapy

Annals of the rheumatic diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Tsz Ching Mok, Chi Chiu Mok
Non-TNF biologics and their biosimilars in rheumatoid arthritis. Expert opinion on biological therapy (2024)
Kamala Vanarsa, Ting Zhang, Jack Hutcheson, Sneha Ravi Kumar, Satyavani Nukala, Haleigh Inthavong, Bruce Stanley, Tianfu Wu, Chi Chiu Mok, Ramesh Saxena, Chandra Mohan
iTRAQ-based mass spectrometry screen to identify serum biomarkers in systemic lupus erythematosus. Lupus science & medicine 11 (1) (2024)
Chi Chiu Mok
Polygenic risk score: the potential role in the management of systemic lupus erythematosus. RMD open 10 (2) (2024)
Kamala Vanarsa, Ting Zhang, Jack Hutcheson, Sneha Ravi Kumar, Satyavani Nukala, Haleigh Inthavong, Bruce Stanley, Tianfu Wu, Chi Chiu Mok, Ramesh Saxena, Chandra Mohan
iTRAQ-based mass spectrometry screen to identify serum biomarkers in systemic lupus erythematosus. Lupus science & medicine 11 (1) (2024)
Tsz Ching Mok, Chi Chiu Mok
Non-TNF biologics and their biosimilars in rheumatoid arthritis. Expert opinion on biological therapy (2024)
Tsz Ching Mok, Chi Chiu Mok
Non-TNF biologics and their biosimilars in rheumatoid arthritis. Expert opinion on biological therapy 24 (7) (2024)
Kamala Vanarsa, Ting Zhang, Jack Hutcheson, Sneha Ravi Kumar, Satyavani Nukala, Haleigh Inthavong, Bruce Stanley, Tianfu Wu, Chi Chiu Mok, Ramesh Saxena, Chandra Mohan
iTRAQ-based mass spectrometry screen to identify serum biomarkers in systemic lupus erythematosus. Lupus science & medicine 11 (1) (2024)
Chi Chiu Mok
Polygenic risk score: the potential role in the management of systemic lupus erythematosus. RMD open 10 (2) (2024)
Chi Chiu Mok
Non-adherence to hydroxychloroquine in systemic lupus erythematosus: The elephant in the clinic room. International journal of rheumatic diseases 27 (5) (2024)
Chi Chiu Mok
Polygenic risk score: the potential role in the management of systemic lupus erythematosus. RMD open 10 (2) (2024)
Chi Chiu Mok
Polygenic risk score: the potential role in the management of systemic lupus erythematosus. RMD open 10 (2) (2024)
Kamala Vanarsa, Ting Zhang, Jack Hutcheson, Sneha Ravi Kumar, Satyavani Nukala, Haleigh Inthavong, Bruce Stanley, Tianfu Wu, Chi Chiu Mok, Ramesh Saxena, Chandra Mohan
iTRAQ-based mass spectrometry screen to identify serum biomarkers in systemic lupus erythematosus. Lupus science & medicine 11 (1) (2024)
Tsz Ching Mok, Chi Chiu Mok
Non-TNF biologics and their biosimilars in rheumatoid arthritis. Expert opinion on biological therapy 24 (7) (2024)
Chi Chiu Mok
Outlook of the jakinibs in systemic lupus erythematous after baricitinib failed. International journal of rheumatic diseases 27 (2) (2024)
Tsz Ching Mok, Chi Chiu Mok
The Potential Use of Arsenic Trioxide in the Treatment of Systemic Lupus Erythematosus. International journal of molecular sciences 25 (17) (2024)
Tsz Ching Mok, Chi Chiu Mok
Non-TNF biologics and their biosimilars in rheumatoid arthritis. Expert opinion on biological therapy 24 (7) (2024)
Chi Chiu Mok
Prognostic Stratification of Lupus Nephritis: The Importance of Renal Histology. The Journal of rheumatology (2023)
Antonis Fanouriakis, Myrto Kostopoulou, Jeanette Andersen, Martin Aringer, Laurent Arnaud, Sang-Cheol Bae, John Boletis, Ian N Bruce, Ricard Cervera, Andrea Doria, Thomas Dörner, Richard A Furie, Dafna D Gladman, Frederic A Houssiau, Luís Sousa Inês, David R W Jayne, Marios Kouloumas, László Kovács, Chi Chiu Mok, Eric F Morand, Gabriella Moroni, Marta Mosca, Johanna Mucke, Chetan B Mukhtyar, György Nagy, Sandra Navarra, Ioannis Parodis, José M Pego-Reigosa, Michelle A Petri, Bernardo A Pons-Estel, Matthias Schneider, Josef S Smolen, Elisabet Svenungsson, Yoshiya Tanaka, Maria G G Tektonidou, Y K Onno Teng, Angela Tincani, Edward M Vital, Ronald F Van Vollenhoven, Chris Wincup, George K Bertsias, Dimitrios T Boumpas
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. Annals of the rheumatic diseases (2023)
Chi Chiu Mok
Targeted Small Molecules for Systemic Lupus Erythematosus: Drugs in the Pipeline. Drugs (2023)
Chi Chiu Mok
Combination strategies for lupus nephritis: facts and controversies. Expert review of clinical immunology (2023)
Chi Chiu Mok, Ho So, Cheuk Wan Yim, Chi Hung To, Weng Nga Lao, Stella Pui Yan Wong, Hoi Yan Ng, Jolly Man Yee Lee, Patrick Man Leung Lee, Shirley King Yee Ying, Moon Ho Leung, Carmen Tze Kwan Ho
Safety of the JAK and TNF inhibitors in rheumatoid arthritis: real world data from the Hong Kong Biologics Registry. Rheumatology (Oxford, England) (2023)
Chi Chiu Mok
Combination strategies for lupus nephritis: facts and controversies. Expert review of clinical immunology (2023)
Chi Chiu Mok
Targeted Small Molecules for Systemic Lupus Erythematosus: Drugs in the Pipeline. Drugs (2023)
Chi Chiu Mok, Yuen Kwan Chung, Carolyn Lee, Ling Yin Ho, Chi Hung To
Relationship between the EULAR/ACR classification criteria and organ damage in systemic lupus erythematosus. Lupus 32 (3) (2023)
Chi Chiu Mok, Yuen Kwan Chung, Carolyn Lee, Ling Yin Ho, Chi Hung To
Relationship between the EULAR/ACR classification criteria and organ damage in systemic lupus erythematosus. Lupus 32 (3) (2023)
Chi Chiu Mok, Chiu Sum Chu, Sau Mei Tse
De novo lupus nephritis after SARS-CoV-2 infection. Lupus (2023)
Chi Chiu Mok, Chiu Sum Chu, Sau Mei Tse
De novo lupus nephritis after SARS-CoV-2 infection. Lupus (2023)
Chi Chiu Mok, Ling Yin Ho, Kar Li Chan, Sau Mei Tse, Chi Hung To
Circulating Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) is Associated with Disease Activity and Risk of Incident Cardiovascular Disease in Patients with Systemic Lupus Erythematosus. Inflammation (2023)
Chi Chiu Mok, Y K Onno Teng, Ramesh Saxena, Yoshiya Tanaka
Treatment of lupus nephritis: consensus, evidence and perspectives. Nature reviews. Rheumatology (2023)
Chi Chiu Mok, Yuen Kwan Chung, Carolyn Lee, Ling Yin Ho, Chi Hung To
Relationship between the EULAR/ACR classification criteria and organ damage in systemic lupus erythematosus. Lupus (2023)
Ho So, Jacqueline So, Tommy Tsz-On Lam, Victor Tak-Lung Wong, Roy Ho, Wai Ling Li, Chi Chiu Mok, Chak Sing Lau, Lai Shan Tam
Performance of the 2017 European Alliance of Associations for Rheumatology/American College of Rheumatology Classification Criteria in Patients With Idiopathic Inflammatory Myopathy and Anti-Melanoma Differentiation-Associated Protein 5 Positivity. Arthritis & rheumatology (Hoboken, N.J.) 74 (9) (2022)
Nuntana Kasitanon, Laniyati Hamijoyo, Meng Tao Li, Kenji Oku, Sandra V Navarra, Yoshiya Tanaka, Chi Chiu Mok
Management of non-renal manifestations of systemic lupus erythematosus: A systematic literature review for the APLAR consensus statements. International journal of rheumatic diseases 25 (11) (2022)
Chi Chiu Mok, Ling Yin Ho, Sau Mei Tse, Kar Li Chan, Chi Hung To
Prevalence and risk factors of herpes zoster infection in patients with rheumatic diseases not receiving biologic or targeted therapies. Clinical rheumatology (2022)
Kamala Vanarsa, Prashanth Sasidharan, Valeria Duran, Sirisha Gokaraju, Malavika Nidhi, Anto Sam Crosslee Louis Sam Titus, Sanam Soomro, Ariel D Stock, Evan Der, Chaim Putterman, Benjamin Greenberg, Chi Chiu Mok, John G Hanly, Chandra Mohan
Aptamer-Based Screen of Neuropsychiatric Lupus Cerebrospinal Fluid Reveals Potential Biomarkers That Overlap With the Choroid Plexus Transcriptome. Arthritis & rheumatology (Hoboken, N.J.) 74 (7) (2022)
Yuen Kwan Chung, Ling Yin Ho, Carolyn Lee, Chi Hung To, Chi Chiu Mok
Validation of the 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in ANA-positive Chinese patients. Therapeutic advances in musculoskeletal disease 14 (2022)
Chi Chiu Mok, Sau Mei Tse, Kar Li Chan, Ling Yin Ho
Estimation of fracture risk by the FRAX tool in patients with systemic lupus erythematosus: a 10-year longitudinal validation study. Therapeutic advances in musculoskeletal disease 14 (2022)
Desmond Yat-Hin Yap, Chi Chiu Mok
Novel and emerging treatment strategies for lupus nephritis. Expert review of clinical pharmacology 15 (11) (2022)
Jacqueline So, Ho So, Victor Tak-Lung Wong, Roy Ho, Tsz Yuen Wu, Priscilla Ching-Han Wong, Lydia Ho-Pui Tam, Chi Ho, Tommy Tsz-On Lam, Yuen Kwan Chung, Wai Ling Li, Chi Hung To, Chak Sing Lau, Chi Chiu Mok, Lai Shan Tam
Predictors of rapidly progressive interstitial lung disease and mortality in patients with autoantibodies against melanoma differentiation-associated protein 5 dermatomyositis. Rheumatology (Oxford, England) 61 (11) (2022)
Kenji Oku, Laniyati Hamijoyo, Nuntana Kasitanon, Meng Tao Li, Sandra V Navarra, Eric F Morand, Yoshiya Tanaka, Chi Chiu Mok
Prevention of infective complications in systemic lupus erythematosus: A systematic literature review for the APLAR consensus statements. International journal of rheumatic diseases 24 (7) (2021)
Meenakshi Jolly, Vinay Sehgal, Shilpa Arora, Desiree Azizoddin, Benzeeta Pinto, Aman Sharma, Herve Devilliers, Mitsuyo Inoue, Sergio Toloza, Ana Bertoli, Ivana Blazevic, Luis M Vilá, Ioana Moldovan, Karina D Torralba, Davide Mazzoni, Elvira Cicognani, Sarfaraz Hasni, Berna Goker, Seminur Haznedaroglu, Josiane Bourre-Tessier, Sandra V Navarra, Ann Clarke, Michael Weisman, Daniel Wallace, Chi Chiu Mok
Does hydroxychloroquine improve patient reported outcomes in patients with lupus? Lupus 30 (11) (2021)
Chi Chiu Mok, Chandra Mohan
Urinary Biomarkers in Lupus Nephritis: Are We There Yet? Arthritis & rheumatology (Hoboken, N.J.) 73 (2) (2021)
Chi Chiu Mok, Sau Mei Tse, Kar Li Chan, Ling Yin Ho
Prevalence and risk factors of herpes zoster infection in patients with biopsy proven lupus nephritis undergoing immunosuppressive therapies. Lupus 29 (8) (2020)
Chi Chiu Mok
Response to: 'Correspondence on 'Long-term outcome of a randomised controlled trial comparing tacrolimus with mycophenolate mofetil as induction therapy for active lupus nephritis'' by Xu. Annals of the rheumatic diseases (2020)
Chi Chiu Mok, Ling Yin Ho, Shirley King Yee Ying, Man Chi Leung, Chi Hung To, Woon Leung Ng
Long-term outcome of a randomised controlled trial comparing tacrolimus with mycophenolate mofetil as induction therapy for active lupus nephritis. Annals of the rheumatic diseases 79 (8) (2020)
Meenakshi Jolly, Bhavika Sethi, Courtney O'Brien, Winston Sequeira, Joel A Block, Sergio Toloza, Ana Bertoli, Ivana Blazevic, Luis M Vilá, Ioana Moldovan, Karina D Torralba, Elvira Cicognani, Davide Mazzoni, Sarfaraz A Hasni, Berna Goker, Seminur Haznedaroglu, Josiane Bourre-Tessier, Sandra V Navarra, Chi Chiu Mok, Ann Clarke, Michael Weisman, Daniel Wallace
Drivers of Satisfaction With Care for Patients With Lupus. ACR open rheumatology 1 (10) (2019)
Chi Chiu Mok, Kwok Hung Chan, Ling Yin Ho, Yim Fong Fung, Wai Fong Fung, Patrick Chiu Yat Woo
Safety and immune response of a live-attenuated herpes zoster vaccine in patients with systemic lupus erythematosus: a randomised placebo-controlled trial. Annals of the rheumatic diseases 78 (12) (2019)
Chi Chiu Mok
Metabolic syndrome and systemic lupus erythematosus: the connection. Expert review of clinical immunology 15 (7) (2019)
Carmen Tze Kwan Ho, Chi Chiu Mok, Tommy Tsang Cheung, Kitty Yan Kwok, Ronald Man Lung Yip, null null
Management of rheumatoid arthritis: 2019 updated consensus recommendations from the Hong Kong Society of Rheumatology. Clinical rheumatology 38 (12) (2019)
Chi Chiu Mok
Herpes zoster vaccination in systemic lupus erythematosus: the current status. Human vaccines & immunotherapeutics 15 (1) (2018)
Chi Chiu Mok
The Jakinibs in systemic lupus erythematosus: progress and prospects. Expert opinion on investigational drugs 28 (1) (2018)